Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer

Science Advances(2020)10.1126/sciadv.aax3931Source: DataRank Database

Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer is a research paper published in Science Advances (2020). On theSindex it has a DataRank of 0. It has been cited 75 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access75 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.04)OA: goldTopics (63)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Aniket S. Wadajkar ORCID,Nina P. Connolly ORCID,Rebeca Galisteo ORCID,Heather M. Ames ORCID,Sen Peng

Live enrichment

PubMed:31998833 OpenAlex:https://openalex.org/W3000096514

National Institutes of Health

Grant: R37 CA218617

National Institutes of Health

Grant: R01NS107813

NCI NIH HHS

Grant: T32 CA154274

NIGMS NIH HHS

Grant: R25 GM055036

FWCI

4.04

Citation Percentile

0.9%

Citation Trend

2014

2020

2021

2022

2023

2024

2025

2026

gold

journalhttps://advances.sciencemag.org/content/advances/6/3/eaax3931.full.pdf

publisherhttps://advances.sciencemag.org/content/advances/6/3/eaax3931.full.pdf

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.aax3931

journalhttps://doi.org/10.1126/sciadv.aax3931

repositoryhttps://pubmed.ncbi.nlm.nih.gov/31998833

Fields of Study

Nanoparticle-Based Drug DeliveryCancer Cells and MetastasisNanoplatforms for cancer theranosticsAnimalsAntineoplastic AgentsBiomarkers, TumorBreast NeoplasmsDisease Models, AnimalExtracellular MatrixFemaleGene ExpressionHumansMiceMolecular Targeted TherapyNanoparticlesNeoplasm MetastasisNeoplasm StagingPrognosisRNA, MessengerTWEAK ReceptorTheranostic NanomedicineTissue DistributionTreatment OutcomeTriple Negative Breast NeoplasmsXenograft Model Antitumor Assays

MeSH Terms

Theranostic NanomedicineTWEAK ReceptorAnimalsAntineoplastic AgentsBreast NeoplasmsDisease Models, AnimalExtracellular MatrixFemaleHumansNeoplasm MetastasisNeoplasm StagingPrognosisRNA, MessengerTissue DistributionBiomarkers, TumorGene ExpressionTreatment OutcomeXenograft Model Antitumor AssaysMiceNanoparticlesMolecular Targeted TherapyTriple Negative Breast Neoplasms

Keywords

NanocarriersPaclitaxelBiodistributionCancer researchMetastatic breast cancerBreast cancerTriple-negative breast cancerCellChemistryCancerMedicinePharmacologyDrugInternal medicineBiochemistryIn vitro

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Facile synthesis of near-infrared responsive on-demand oxygen releasing nanoplatform for precise MRI-guided theranostics of hypoxia-induced tumor chemoresistance and metastasis in triple negative breast cancer

10.6084/m9.figshare.19311782.v1figshare

10.6084/m9.figshare.19311782figshare

Additional file 1 of Three birds with one stone: co-encapsulation of diclofenac and DL-menthol for realizing enhanced energy deposition, glycolysis inhibition and anti-inflammation in HIFU surgery

10.6084/m9.figshare.19727504.v1figshare

Additional file 1 of Three birds with one stone: co-encapsulation of diclofenac and DL-menthol for realizing enhanced energy deposition, glycolysis inhibition and anti-inflammation in HIFU surgery

10.6084/m9.figshare.19727504figshare